UNSPSC 51291600: Antidepressant acridines

This classification denotes antidepressant drugs made from structures based on C13H9N.

UNSPSC 51291600 Antidepressant acridines is a Class code with a notable mismatch between its nominal scope and recent state and local procurement activity. The code itself denotes a specific pharmaceutical class used in antidepressant treatment, but the most recent opportunities tagged to it reflect a broader procurement pattern: state and local governments are buying naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer pharmaceutical supply chain solutions (Texas Health and Human Services Commission), and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations targets antidepressant acridines specifically. The issuing bodies mix state agencies (Texas HHS Commission, Minnesota Department of Administration), counties (Seminole County), and regional cooperative purchasing organizations (MMCAP). The code shows little relevant recent activity aligned to its stated pharmaceutical class.

Recent opportunities span Florida, Texas, and Minnesota, reflecting a multistate cooperative structure. Seminole County posted an IFB for naloxone and drug deactivation systems on June 30, 2026, with a response deadline of July 26, 2023 (note the historical date discrepancy in the source); the procurement seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. Texas HHS issued RFI HHS0017013 on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs for a future Therapeutic Pharmacy Initiative, signaling early-stage procurement strategy development rather than immediate award activity. Minnesota's MMCAP released an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, establishing contracts effective July 1, 2026 across participating state and local government facilities in multiple states including Oregon. The code's nominal scope—antidepressant acridines—does not align with these actual purchases, suggesting either miscategorization in the state and local procurement systems or a disconnect between UNSPSC coding practice and the pharmaceutical products actually being procured.